Sony received 510k clearance for its OR integration system, NUCLeUS, which allows surgeons to connect numerous instruments, screens and other applications to one platform. Sony has been selling the technology in Europe, and can now market and sell it in the U.S.
While the Apple Watch and other wearables have made significant inroads in the consumer arena, Sony felt the market could use a more robust B2B approach.
On the heals of a year fraught with high-profile data breaches, the risk is now greater than ever, and within healthcare, the threat is “persistent and growing” and could reach $5.6 billion next year, according to a report from Experian. It’s not hard to figure out why – an explosion of data and the realization that personal […]
Eighteen companies from outside healthcare have entered the medtech market, including Qualcomm, Sony, Verizon, AT&T, Canon, Samsung and Motorola, according to PwC’s latest report on medtech and innovation. While medtech companies still work to chip away slowly at what innovation means–literally without a definition, big companies from the tech and IT space dive in. “I […]
As medtech gets sleeker, more mobile and all-around better looking, look to these six devices–from biosensors to exam tables–for tips to follow in device design. (Hint: pediatric medtech is winning this round, followed closely by biosensors.) [imagebrowser id=20]
Repurposing its interest in 3-D imaging, Sony has created an endoscope video-imaging processor that’s distinct because of its wearability. Surgeons put this one on their heads. On Aug. 1, doctors in Japan will be able to use a “a head-mount image processing unit capable of receiving and outputting endoscope image signals, or controlling video images, […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
